CRISPR Therapeutics AG is rated a Buy with $1.9B cash, prudent management, and undervalued shares. Learn more about CRSP ...
From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.
The FDA previously placed two clinical studies on hold, including the Phase III trial in which the liver toxicity occurred. Intellia is working with experts to create a risk management program for nex ...
Pioneering CRISPR trial shows single infusion permanently lowers bad cholesterol by 50% in patients who don't respond to medication.
His decoding of the blueprint for life with Francis H.C. Crick made him one of the most important scientists of the 20th ...
The inaugural Genetic Agency Technology Conference (GATC) gathered a group of researchers and entrepreneurs to discuss the vision for AI-based genetic medicine.
Access to funding, technology fragmentation, and a misalignment with farmers’ needs are perennial barriers to the adoption of ...
Food shortages are worsening, and although a more cooperative social and scientific vision offers hope, if the crisis is ...
The convergence of AI, quantum computing, and biosciences is propelling the global healthcare industry into a new era - now ...
Climate Compass on MSN
Scientific Theories Once Dismissed That Are Now Supported by Evidence
Continental Drift Theory - When Continents Were Supposed to Stand Still When meteorologist Alfred Wegener proposed in 1912 ...
MedPage Today on MSN
Gene Therapy Shows Promise for Cutting LDL in Half in Tough-to-Treat Dyslipidemia
N EW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that was unresponsive to lipid-lowering therapy, according to a phase I trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results